Deep 6 AI

AI-driven patient recruitment for clinical trials

Pasadena, California, United States

About Deep 6 AI

Deep 6 AI uses artificial intelligence to speed up the process of finding patients for clinical trials. By analyzing medical records, their system can quickly identify patients who meet the specific criteria needed for trials, which usually takes a long time when done manually. This service is mainly aimed at pharmaceutical companies, research organizations, and healthcare providers, helping them recruit patients faster and complete trials more efficiently. Unlike traditional methods that can take months, Deep 6 AI's technology allows for patient recruitment in just minutes. This not only helps clients finish their trials sooner but also reduces the costs associated with drug development, making treatments more affordable for patients. The company's goal is to improve the clinical research process, ensuring that patients have quicker access to new therapies and that drug development is more efficient.

Pasadena, CaliforniaHeadquarters
2015Year Founded
$17MTotal Funding
SERIES_ACompany Stage
Enterprise Software, AI & Machine Learning, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Vacation
Paid Sick Leave
401(k) Retirement Plan
Remote Work Options

Risks

Emerging AI startups may threaten Deep 6 AI's market share.
Inaccurate EMR data could lead to incorrect patient matching.
Continuous platform updates are needed to stay competitive, straining resources.

Differentiation

Deep 6 AI uses AI to expedite patient recruitment for clinical trials.
The platform analyzes both structured and unstructured clinical data for precision matching.
Deep 6 AI offers a SaaS model, providing scalable solutions for various client sizes.

Upsides

AI in clinical trials market projected to grow with a 12.4% CAGR by 2030.
Partnership with Texas Tech enhances patient access to clinical trials.
AI integration with EMR systems improves real-time patient matching capabilities.

Funding

Total raised$16.97 M
Latest valuation$85.00 M
StageSERIES_A
SERIES A
10/31/2019
$17
$85.00 M
SEED
11/30/2018
N/A
$1.25 M